Growth-Factor peptides: studied in relation to growth hormone pathways
A synthetic GHRH analog. It is FDA-approved under the brand Egrifta for one specific condition — HIV-associated lipodystrophy — and is not approved for general weight loss, body composition, or anti-aging use.
This page is for education and does not provide medical advice, diagnosis, treatment, or a recommendation to buy or use any product. The compound described may not be approved by the FDA for human use. Approval status and regulations change; information is current as of this page's last update. Time Kapsule provides only supervised, FDA-approved protocols and does not sell, supply, or endorse research-use-only peptides. Consult a licensed clinician before considering any therapy.

